Heron Therapeutics, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| RUBRIC CAPITAL MANAGEMENT LP | 11/13/2024 | 26.71 M | $53.16 M | 0.00% | 17.48% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 11/14/2024 | 8.85 M | $17.61 M | 16.45% | 5.79% |
| VANGUARD GROUP INC | 11/13/2024 | 8.72 M | $17.35 M | 1.21% | 5.71% |
| BLACKROCK FUNDING, INC. /DE | 11/13/2024 | 8.53 M | $16.98 M | 100.00% | 5.58% |
| VELAN CAPITAL INVESTMENT MANAGEMENT LP | 11/14/2024 | 6.99 M | $13.90 B | 0.00% | 4.57% |
| TEJARA CAPITAL LTD | 11/13/2024 | 5.31 M | $10.56 M | 26.70% | 3.47% |
| D. E. SHAW & CO., INC. | 11/14/2024 | 4.38 M | $8.73 M | 13.49% | 2.87% |
| PALISADE CAPITAL MANAGEMENT, LP | 11/14/2024 | 3.99 M | $7.94 M | -1.40% | 2.61% |
| STATE STREET CORP | 11/14/2024 | 3.19 M | $6.35 M | -39.55% | 2.09% |
| GEODE CAPITAL MANAGEMENT, LLC | 11/12/2024 | 3.05 M | $6.06 M | -2.15% | 1.99% |
| JW ASSET MANAGEMENT, LLC | 11/08/2024 | 2.29 M | $4.56 M | 0.00% | 1.50% |
| CLEARLINE CAPITAL LP | 11/14/2024 | 2.23 M | $4.43 B | 48.90% | 1.46% |
| RENAISSANCE TECHNOLOGIES LLC | 11/13/2024 | 2.01 M | $4.00 M | 0.72% | 1.31% |
| ORCHARD CAPITAL MANAGEMENT, LLC | 11/13/2024 | 1.98 M | $3.95 M | -11.73% | 1.30% |
| CONGRESS PARK CAPITAL LLC | 10/09/2024 | 1.98 M | $3.94 M | 25.31% | 1.29% |
| TANG CAPITAL MANAGEMENT LLC | 11/14/2024 | 1.85 M | $3.68 M | 0.00% | 1.21% |
| MORGAN STANLEY | 11/14/2024 | 1.77 M | $3.52 M | 130.30% | 1.16% |
| MARSHALL WACE, LLP | 11/14/2024 | 1.72 M | $3.41 M | -2.58% | 1.12% |
| GOLDMAN SACHS GROUP INC | 11/14/2024 | 1.71 M | $3.40 M | 20.64% | 1.12% |
| MONACO ASSET MANAGEMENT SAM | 11/07/2024 | 1.68 M | $3.34 M | 10.92% | 1.10% |
| CITADEL ADVISORS LLC | 11/14/2024 | 1.59 M | $3.17 M | 194.04% | 1.04% |
| TWO SIGMA INVESTMENTS, LP | 11/14/2024 | 1.40 M | $2.79 M | 26.72% | 0.92% |
| NEW YORK STATE COMMON RETIREMENT FUND | 10/28/2024 | 1.28 M | $2.55 M | 2.81% | 0.84% |
| QUBE RESEARCH & TECHNOLOGIES LTD | 11/14/2024 | 1.15 M | $2.28 M | 126.06% | 0.75% |
| NUVEEN ASSET MANAGEMENT, LLC | 11/14/2024 | 1.11 M | $2.20 M | -6.23% | 0.72% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 11/12/2024 | 1.10 M | $2.18 M | -3.64% | 0.72% |
| BANK OF AMERICA CORP /DE/ | 11/14/2024 | 955,928 | $1.90 M | 120.11% | 0.63% |
| MILLENNIUM MANAGEMENT LLC | 11/14/2024 | 934,388 | $1.86 M | -34.87% | 0.61% |
| AQR CAPITAL MANAGEMENT LLC | 11/14/2024 | 900,107 | $1.79 M | 48.25% | 0.59% |
| TWO SIGMA ADVISERS, LP | 11/14/2024 | 811,371 | $1.61 M | 614.86% | 0.53% |
| SQUAREPOINT OPS LLC | 11/14/2024 | 612,897 | $1.22 M | 68.52% | 0.40% |
| GSA CAPITAL PARTNERS LLP | 11/05/2024 | 512,736 | $1.02 M | 18.40% | 0.34% |
| RICHMOND BROTHERS, INC. | 11/12/2024 | 510,782 | $1.02 M | 43.25% | 0.33% |
| CM MANAGEMENT, LLC | 11/12/2024 | 500,000 | $995,000 | 66.67% | 0.33% |
| WELLINGTON MANAGEMENT GROUP LLP | 11/14/2024 | 496,227 | $987,491 | -4.79% | 0.32% |
| NEXPOINT ASSET MANAGEMENT, L.P. | 11/14/2024 | 475,750 | $946,743 | 0.00% | 0.31% |
| ZACKS INVESTMENT MANAGEMENT | 11/14/2024 | 475,575 | $946,395 | 2.44% | 0.31% |
| FMR LLC | 11/13/2024 | 431,906 | $859,493 | 26.18% | 0.28% |
| HRT FINANCIAL LP | 11/12/2024 | 426,817 | $849,000 | 100.00% | 0.28% |
| BANK OF NEW YORK MELLON CORP | 11/12/2024 | 340,739 | $678,072 | -24.15% | 0.22% |
| JANE STREET GROUP, LLC | 11/15/2024 | 332,126 | $660,930 | -5.35% | 0.22% |
| XTX TOPCO LTD | 11/14/2024 | 297,568 | $592,160 | 448.97% | 0.19% |
| KBC GROUP NV | 11/06/2024 | 289,269 | $576,000 | 0.00% | 0.19% |
| APEIRON RIA LLC | 11/14/2024 | 243,542 | $484,649 | 29.11% | 0.16% |
| LOS ANGELES CAPITAL MANAGEMENT LLC | 11/04/2024 | 220,834 | $439,460 | -7.56% | 0.14% |
| BARCLAYS PLC | 11/19/2024 | 218,455 | $434,000 | 29.77% | 0.14% |
| D.A. DAVIDSON & CO. | 11/13/2024 | 213,630 | $425,124 | -2.24% | 0.14% |
| JPMORGAN CHASE & CO | 11/08/2024 | 206,711 | $411,355 | 295.82% | 0.14% |
| ALLIANCEBERNSTEIN L.P. | 11/14/2024 | 198,550 | $395,115 | 0.00% | 0.13% |
| RHUMBLINE ADVISERS | 11/12/2024 | 175,786 | $349,802 | -4.71% | 0.12% |
Heron Therapeutics, Inc.institutional Ownership - FAQ's
During the previous two years, 265 institutional investors and hedge funds held shares of Heron Therapeutics, Inc.. The most heavily invested institutionals were:
Rubric Capital Management LP: 26.71 M
ADAGE CAPITAL PARTNERS GP, L.L.C.: 8.85 M
VANGUARD GROUP INC: 8.72 M
BlackRock Funding, Inc. /DE: 8.53 M
Velan Capital Investment Management LP: 6.99 M
Tejara Capital Ltd: 5.31 M
79.71% of Heron Therapeutics, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 141.47 M shares in the last 24 months. This purchase volume represents approximately $223.52 M in transactions.